Lateral Window Versus Intralift™ Sinus Floor Elevation

July 31, 2020 updated by: Dr. France LAMBERT, University of Liege

Intraoperative and Postoperative Outcomes of Sinus Floor Elevation Using Lateral Window Technique Versus Hydrodynamic Transalveolar Approach: A Randomized Controlled Trial

Several approaches have been used in order to regenerate bone in the upper jaw in case of insufficient alveolar bone height for implant placement. However, new emerging techniques need to be assessed and compared to conventional methods in order to define their potential indications.

The purpose of the present randomized controlled clinical trial was to compare the clinical outcomes of two sinus floor elevation techniques: conventional lateral window technique versus a novel transalveolar approach using hydrodynamic ultrasonic device.

Study Overview

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • edentulism in the posterior maxilla (unitary or plural)
  • need of a sinus floor augmentation procedure before implant placement

Exclusion Criteria:

  • any uncontrolled systemic disease
  • ongoing chemo- or radiotherapy
  • history of maxillary sinus diseases or acute sinus-related issues

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control - Lateral window
Standard surgical technique to access maxillary sinus for sinus floor augmentation procedure.
Experimental: Test - Hydrodynamic transalveolar approach
Novel transalveolar approach (using an ultrasonic device) to access maxillary sinus for sinus floor augmentation procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sinus membrane perforation
Time Frame: During the surgery (from beginning to end)
Presence/absence of sinus membrane perforation during the surgery
During the surgery (from beginning to end)
Surgical procedure duration
Time Frame: From beginning of surgery until the end of surgery
The time measurement started from the administration of local anesthesia and ended when the placement of final suture was completed. The time was measured using a stopwatch.
From beginning of surgery until the end of surgery
Edema
Time Frame: From the end of surgery up to 1 week postoperatively
Presence/absence of edema postoperatively
From the end of surgery up to 1 week postoperatively
Hematoma
Time Frame: From the end of surgery up to 1 week postoperatively
Presence/absence of hematoma postoperatively
From the end of surgery up to 1 week postoperatively
Postsurgical bleeding
Time Frame: From the end of surgery up to 1 week postoperatively
Presence/absence of bleeding postoperatively
From the end of surgery up to 1 week postoperatively
Nasal discharge
Time Frame: From the end of surgery up to 1 week postoperatively
Presence/absence of nasal discharge postoperatively
From the end of surgery up to 1 week postoperatively
NSAID consumption
Time Frame: From the end of surgery up to 1 week postoperatively
Quantification of NSAID consumption per day up to 1 week postoperatively (tablets/per day)
From the end of surgery up to 1 week postoperatively
Patient related outcome measures (PROMs)
Time Frame: From right before the surgery up to 1 week postoperatively
PROMs were assessed with a questionnaire using a visual analogue scale (VAS), which was given to all participants in order to assess their perception before, during, and after the intervention. A graduated scale from 0 to 10 was used, with a lower score presenting a better outcome.
From right before the surgery up to 1 week postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic outcomes
Time Frame: From the baseline (surgery procedure) up to 1 year post-surgery
Radiographic (CBCT) qualitative assessment of the gained volume (change in volume from baseline to 1 year postoperatively).
From the baseline (surgery procedure) up to 1 year post-surgery
Implant survival rates
Time Frame: From the baseline (surgery procedure) up to 1 year post-surgery
Implant survival rates assessment at 1 year postoperatively.
From the baseline (surgery procedure) up to 1 year post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2013

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

July 14, 2020

First Submitted That Met QC Criteria

July 31, 2020

First Posted (Actual)

August 5, 2020

Study Record Updates

Last Update Posted (Actual)

August 5, 2020

Last Update Submitted That Met QC Criteria

July 31, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • B707201316423

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraoperative Outcomes

Clinical Trials on Sinus floor elevation

3
Subscribe